Search: 2017 EU Meeting Faculty
Results 41 - 59 of 59

Christopher Rains

VP, Global Medical Affairs
Shire


Type of Company:
Biotechnology
Professional Degrees: CMPP, PharmD
CMPP Certified: (9/2010)

Bio: Chris is Head of the Global Medical Affairs - Medical Shared Services group at Shire, which includes the Global Publications Group. Shire continues to be a leader in navigating a path through the changing and challenging environment, and in shaping publication practices for the biopharmaceutical industry.

Chris Rapier

Director, Global Medical Communications
Merck KGAA


Bio: Chris Rapier is an experienced Medical Communications professional. He is currently Global Medical Director of Medical Communications at Merck KGAA in Germany, with responsibility for oncology publications. He has a strong agency background, having worked in the industry since 2005, including senior roles at GeoMed and Gardiner-Caldwell Communications. Chris has extensive experience of strategic publication planning and delivery, specializing in oncology and immunotherapy. He holds a PhD in Molecular Biology.

Nicole Rapior

Head of Global Scientific Communications, Medicine Operations
Boehringer Ingelheim Pharma GmbH & Co. KG


Type of Company:
Pharmaceutical
Professional Degrees: MS, PhD

Bio: Nicole has headed since 2012 the Global Scientific Communications Team at Boehringer Ingelheim which is responsible for the planning and development of all global scientific publications for Boehringer Ingelheim's main therapeutic areas, respiratory, cardiovascular and metabolic diseases as well as oncology, immunology and CNS. In total, she has 8 years of experience within the field of scientific publications having also worked as Global Publications Strategy Manager in prior roles at Boehringer Ingelheim, Warner Chilcott Pharmaceuticals and Procter & Gamble Pharmaceuticals. Nicole holds a Ph.D. in Biochemistry and a Master degree in Advanced Oncology.

Susan Scott

Director
Scott Pharma Solutions Ltd


Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (2/2009)

Bio: Since 2014, Susan Scott has been a director of Scott Pharma Solutions Ltd, providing consultancy in the arena of disclosure of clinical trials as scientific publications and on clinical trial registries. For a decade before that, she was the Director of Publications & Communications for Ipsen, a mid-size European pharmaceutical company. Responsible for establishing and building their global publication management function, she also created and led the group managing clinical trial registration and results posting. With a PhD in biochemistry from University of London, she previously worked for GSK as a project leader in neurology having gained extensive experience in clinical study management in several therapeutic areas for its heritage companies. She is accredited with the Certificate of Medical Publication Professionals (CMPP), and is now on the ISMPP Recertification committee. She has presented or chaired sessions at numerous ISMPP, DIA and CBI Publication conferences in Europe and the US.

Gavin Sharrock

Business Development Director, Society Services
Wiley
-OX136AN


Type of Company:
Publisher
Professional Degrees: CMPP
CMPP Certified: (9/2015)

Bio: Gavin Sharrock is Business Development Director, Society Services Team, Wiley. Gavin started his career at Wiley (formerly Blackwell Publishing) as a Production Editor in Content Management, before moving on to become a Journal Publishing Manager and then a Publisher in Editorial, and then moving into business development in a Business Innovations group. He has considerable experience in digital product development in a publishing environment, and in working with corporate clients, particularly in the Pharma industry. He now works in the Society Services Team and is responsible for working with societies to generate more revenue from industry, principally through their publications. This includes looking at new content-driven products and services for corporate clients, as well as making sure that the partnerships that we facilitate between industry and societies promote and strengthen the brand of the journal and society and provide value to the end users. He believes that sustainable corporate revenues can only be attained if the primary driver is not money, but value to the society member or journal reader.

Steve Smith

Director
iS Health Group


Siobhan Southam

Global Publications Manager
AstraZeneca


Bio: Siobhan is an experienced global communications and medical affairs professional and is currently leading activities for a number of respiratory programmes. Siobhan's role is to develop communication and publication strategies to communicate science, medicines and health in a meaningful way to all audiences. Siobhan has a broad range and depth of experience across respiratory, inflammation, neuroscience, oncology and infection. Prior to her current role, Siobhan was responsible for a product in late stage development for gout and successfully led the scientific communications as well as an innovative project engaging with patients. Siobhan has a broad range and depth of experience across respiratory, inflammation, neuroscience, oncology and infection gained in communications, pharmaceutical industry and research environments. Siobhan graduated from Leeds University with a BSc in Microbiology and has post-graduate diplomas in marketing and neurolinguistic programming.

Stuart Spencer

Sr. Executive Editor
The Lancet


Bio: Stuart joined The Lancet in 1999 and throughout his time there has led the Fast Track team that aims to select, review and publish prestigious manuscripts within 4 weeks of receipt. Although dealing with all areas of research, he deals with most of the cardiology submissions. After graduating Stuart moved into research which started at the Brompton Hospital, London, looking at scoliosis in children before moving to the Veterinary School site at Bristol University. During this period he was invited to establish a research unit in The Netherlands. Later he set up a research team for a major pharmaceutical company in Switzerland for a year, and then spent 9 years as a senior researcher in New Zealand. He has also had two senior research fellowships at Leuven University, Belgium, and visiting professorships at Kings College, London and Hong Kong University, and a doctorate of medicine from Umea University, Sweden. Stuarts research expertise includes such diverse topics as, growth, neuroendocrinology, immunology and fetal development . He also had a Senior Fellowship in bioethics for 5 years. This broad research base in front-line research has given a clear understanding of principles in research and publications applicable across disciplines. Stuart is also a Trustee of the Scoliosis Association (UK), is on the British Scoliosis Research Fund grants committee and the Steering Committee of the Swedish National GP Research School.

Richard Stephens

Editor-in-Chief
BioMed Central


Bio: Richard is a survivor of two cancers, a heart emergency and sundry other health challenges. He has acted as a carer for family members with both mental health and physical problems. Richard's interest in research comes from his own experiences as a patient, and as a participant in four clinical trials and eleven other research studies. He is the joint Editor-in-Chief of BMC's Journal of Research Involvement and Engagement, in some ways a natural extension from his secondary career as a freelance journalist (mostly sports) and author (mostly local history). His main professional life was spent in education and in local government, but Richard is now a full-time patient advocate in research, driven by a desire to make sure that research outcomes benefit patients, and that the process of participating is made as easy as possible so that patients can help bring benefits to other patients. He Chairs the (UK) National Cancer Research Institute's Consumer Forum and serves with several other international and national committees and bodies, such as EORTC, Eupati, MRC CTU, Genomics England and CRUK. His roles include advisory, funding, and priority-setting work. When time allows, Richard engages in a battle of wills with a gym treadmill, and enjoys sleeping.

Myint Tin Tin Htar

Director, Global Clinical Epidemiology
Pfizer France


Bio: Tin Tin is a medical doctor with post-graduate trainings on public health, epidemiology and vaccinology. She joined vaccine industry in 2006 and worked for medical affairs Sanofi-Pasteur MSD and Pfizer for over 10 years and is currently director at Global Clinical Epidemiology department at Pfizer Vaccines. She was involved in rotavirus and pneumococcal vaccines post-licensure activities. She is also a member of ADVANCE, public-private collaboration for Accelerated development of vaccine benefit-risk collaboration in Europe. Main areas of interest are vaccine preventable diseases, observational studies, infectious disease surveillance, vaccine policy, private-public partnership.

Christine Vanderlinden

Director Publications Management Team, Scientific & Public Disclosure
GSK Biologicals


Type of Company:
Pharmaceutical
Professional Degrees: CMPP
CMPP Certified: (9/2011)

Bio: Christine Vanderlinden, Director, Head Publications Management Team - GSK Vaccines Christine is a biologist with a PhD in Marine Biology and Pharmacology. Her role as Publications Manager and later as Publications Lead for different vaccine projects within GSK has allowed her to develop into this area and gain extended experience in good publication practices and ethics. In her current function as Head of the Publications Management team, Christine oversees a global team of publications professionals covering all GSK vaccine projects. Christine is also a certified ISMPP medical publication professional (CMPP), an accredited member of EMWA and was an EMWA workshop leader giving a course on Medical Writing for Vaccines.

Steven Walker

Director and Co-Owner
St Gilesmedical London & Berlin


Type of Company:
Communications Agency
Professional Degrees: MD, MEd, MS
CMPP Certified: (3/2016)

Bio: Steven has degrees in medicine, education and clinical oncology. He trained in the UK, USA and Germany. His focus is on building St Gilesmedical's team of medics, scientists, writers and educators in London and Berlin into a major health communication company. Current interests include medical and regulatory writing, teaching and delivery of effective meetings. Steven is active in ISMPP, EMWA and lectures at Manchester Metropolitan University. St Gilesmedical also supports non-commercial education and research activities in the UK and Germany. The needs of patients and healthcare professionals are at the centre of everything we do.

Al Weigel

President/CEO
ISMPP

CMPP Certified: (2/2009)

Bio: Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. Al earned his Masters of Education at the University of the Arizona and currently is a ISMPP Certified Medical Publication Professional (CMPP).

Richard White

Commercial Director
Oxford PharmaGenesis Ltd


Type of Company:
Communications Agency
Professional Degrees: MA, PhD

Bio: Richard White is Commercial Director of Oxford PharmaGenesis, an independent HealthScience communications consultancy. He has more than 18 years of experience in medical communications, and has led launch publications plans for products across a broad range of therapy areas. Richard is a member of the International Society for Medical Publications Professionals (ISMPP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute of Directors. He was a reviewer of the GPP2 and GPP3 guidelines, and has personally authored 17 publications in peer-reviewed journals. Richard has also published white papers on good publication practice, value demonstration and rare diseases in Pharmaceutical Marketing Europe, is an invited author of articles for ISMPP's MAP e-newsletter, and is on the Editorial Board of Drugs in Context. Richard founded the Oxford PharmaGenesis Value Demonstration Practice to apply good publication practice and communications expertise to HEOR, RWE and patient-reported outcomes (PRO) studies. He has run training workshops in these areas for multiple pharma companies and academic institutions, and has delivered invited presentations, educational webinars and moderated roundtable discussions on publications and communications best practice in HEOR, RWE and PROs at the ISMPP and TIPPA Annual Meetings. Richard was Chair of the 2017 TIPPA Annual Meeting. Before joining Oxford PharmaGenesis, Richard gained his MA and PhD in Natural Sciences from the University of Cambridge, UK. His PhD research won the 1998 Glaxo Wellcome Young Investigator's Award, and he was awarded a Research Fellowship in Pharmacology at Sidney Sussex College, Cambridge. He has completed the Advanced Health Economic Modeling Programme at the University of Oxford, is an alumnus of the International Marketing Programme at INSEAD, and is a member of Green Templeton College, University of Oxford, UK.

Sophia Whitman

Research Lead & Medical Writer
Stgilesmedical


Bio: Sophia is a medical writer at Stgilesmedical where she undertakes a range of projects, including regulatory writing and manuscript preparation. She has degrees in medicine, psychology and immunology. Prior to studying medicine and becoming a medical writer, Sophia coordinated clinical trials in health psychology research.

Jurgen Wiehn

Director, Scientific Publications
Shire


Type of Company:
Pharmaceutical
Professional Degrees: CMPP, PhD
CMPP Certified: (9/2011)

Bio: Jurgen, PhD, ISMPP CMPP, has over 15 years of international pharmaceutical/biotech experience in medical affairs and clinical development (Publications/Scientific and Regulatory Writing; Medical Information, Communication and Education). Prior to industry career, Jurgen studied biology, gained his PhD in Finland and lead academic research programs in Finland and Switzerland. His industry experience comes from Orion Pharma, Merck Serono, Ferring Pharmaceuticals and, most recently, from Shire, where Jurgen works as a Director, Global Scientific Publications since 2011.

Steve Winter

Global Publications Leader, Global Medical Affairs
AstraZeneca


Type of Company:
Pharmaceutical
Professional Degrees: PhD
Other Degrees*: BPharm
CMPP Certified: (3/2016)

Bio: Steve is a former pharmacist, with a PhD in cardiovascular pharmacology (University of Bath, UK). Having completed his academic studies, Steve commenced his career in medical communications, first within the agency sector and most recently with various pharmaceutical and diagnostic/device companies in Switzerland and the UK. He is currently Global Publications Leader for AstraZeneca (UK). Steve obtained his CMPP certification in March of 2016.

Ryan Woodrow

Director
Aspire Scientific Ltd


Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP
CMPP Certified: (3/2012)

Bio: Ryan Woodrow is a co-owner of Aspire Scientific Ltd (www.aspire-scientific.com) -- a medical writing agency -- and has almost 20 years of experience of working within pharmaceutical companies and in senior editorial positions within medical communications agencies. Over his career, Ryan has gained extensive experience of developing and implementing medical publication and communication plans for the pharma industry, and has a good knowledge of a number of therapeutic areas. Ryan is conversant in the latest ethical guidelines, serves on the European Committee for the International Society for Medical Publication Professionals (ISMPP), is a Certified Medical Publication Professional (CMPP) and helps to organise educational, careers and networking events for the European medical communications community. Ryan can be contacted by email (ryan.woodrow@aspire-scientific.com).

Yvonne Yarker

President
Medicite LLC
-5784


Type of Company:
Consultant/Freelance
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (2/2009)

Bio: Yvonne is a highly skilled medical communications specialist with an outstanding career in medical writing, content development, and publication planning for the pharmaceutical and biotech industries. She has more than 25 years of experience in medical and scientific content development in most therapeutic areas and across all types of medical and scientific communications, with a focus on oncology and hematology. Expert in compliance, publication ethics, and best practices. She also has 15 years of experience at a managerial level with strong communications, scientific, financial, and interpersonal skills.
<< first < Prev 1 2 3 Next > last >>